Literature DB >> 23255916

Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.

Jiabo Hu1, Zhongwei Zhou, Shunbin Shi, Xiaozhong Zhu, Xiaohui Wang, Wei Zhang, Sanqiang Hu, Hui Qian, Wenrong Xu.   

Abstract

Mesenchymal stem cells (MSCs) or MSC-like cells have now been isolated from various sites, including different types of tumor tissues. Whether MSCs or MSC-like cells in different tumor tissues possess differentiated biological characteristics remains unclear, and the correlation between MSCs or MSC-like cells and tumors has been a controversial topic. In the present study, we isolated MSC-like cells from human esophageal carcinoma (hEC-MSCs) and adjacent non-cancerous tissues (hECN-MSCs). Although the two types of MSC-like cells were in different microenvironments and had certain differences, they possessed similar morphological properties and surface antigens, including CD13, CD29, CD44 and CD105. Our results indicated that hEC-MSCs and hECN-MSCs are similar in a number of ways. This may have implications for further research on the esophageal carcinoma microenvironment and its pathological mechanism.

Entities:  

Year:  2012        PMID: 23255916      PMCID: PMC3525354          DOI: 10.3892/ol.2012.1003

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation.

Authors:  Pieternella S In 't Anker; Sicco A Scherjon; Carin Kleijburg-van der Keur; Willy A Noort; Frans H J Claas; Roelof Willemze; Willem E Fibbe; Humphrey H H Kanhai
Journal:  Blood       Date:  2003-08-15       Impact factor: 22.113

2.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

3.  Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.

Authors:  Wen-ting Xu; Zhen-yu Bian; Qi-ming Fan; Gang Li; Ting-ting Tang
Journal:  Cancer Lett       Date:  2009-04-01       Impact factor: 8.679

4.  Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells.

Authors:  Jai-Hee Moon; Sung Sik Kwak; Gyuman Park; Hye-Youn Jung; Byung Sun Yoon; Jaeyeo Park; Kyung Su Ryu; Seung-Cheol Choi; Isaac Maeng; Bona Kim; Eun Kyung Jun; Soonseong Kim; Aeree Kim; Sejong Oh; Hyunggee Kim; Ki Dong Kim; Seungkwon You
Journal:  Stem Cells Dev       Date:  2008-08       Impact factor: 3.272

5.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors:  C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

7.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung.

Authors:  Mauricio Rojas; Jianguo Xu; Charles R Woods; Ana L Mora; Willy Spears; Jesse Roman; Kenneth L Brigham
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-12       Impact factor: 6.914

Review 8.  The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles.

Authors:  B Hall; M Andreeff; F Marini
Journal:  Handb Exp Pharmacol       Date:  2007

9.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Authors:  Pravin J Mishra; Prasun J Mishra; Rita Humeniuk; Daniel J Medina; Gabriela Alexe; Jill P Mesirov; Sridhar Ganesan; John W Glod; Debabrata Banerjee
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.

Authors:  Aarif Y Khakoo; Shibani Pati; Stasia A Anderson; William Reid; Mohamed F Elshal; Ilsa I Rovira; Ahn T Nguyen; Daniela Malide; Christian A Combs; Gentzon Hall; Jianhu Zhang; Mark Raffeld; Terry B Rogers; William Stetler-Stevenson; Joseph A Frank; Marvin Reitz; Toren Finkel
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  3 in total

1.  Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration.

Authors:  Yoshitaka Suda; Shinya Neri; Hiroko Hashimoto; Youichi Higuchi; Masayuki Ishibashi; Masato Sugano; Kenkichi Masutomi; Masahiro Tsuboi; Atsushi Ochiai; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-27       Impact factor: 4.553

2.  Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.

Authors:  F Liotta; V Querci; G Mannelli; V Santarlasci; L Maggi; M Capone; M C Rossi; A Mazzoni; L Cosmi; S Romagnani; E Maggi; O Gallo; F Annunziato
Journal:  Br J Cancer       Date:  2015-02-03       Impact factor: 7.640

3.  Phenotypic, Functional, and Safety Control at Preimplantation Phase of MSC-Based Therapy.

Authors:  Wioletta Lech; Anna Figiel-Dabrowska; Anna Sarnowska; Katarzyna Drela; Patrycja Obtulowicz; Bartlomiej Henryk Noszczyk; Leonora Buzanska; Krystyna Domanska-Janik
Journal:  Stem Cells Int       Date:  2016-08-29       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.